Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: A 38-gene model comprised of key TET2-associated genes shows additive utility to high-risk prostate cancer cases in the prognostication of biochemical recurrence

Fig. 3

Multivariate Kaplan-Meier curve for prediction of BCR in the validation (TCGA) cohort. Binary 38G model is assessed alongside CAPRA-S divided into two categories: low-risk/intermediate risk, or high-risk. Log-rank p-values for pairwise comparisons are indicated in the accompanying chart. Overall log-rank p-value is indicated on the graph. Below: Risk table indicating the number of patients in each group at risk at various timepoints. Figure generated using the R (v3.6.1) package survminer (v0.4.6)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us